Looks like the gloves are finally coming off and someone is standing up to the FDA over their dysfunctional relationship to consumer health.
Since then, the plot has thickened. On Friday, July 31, several plaintiffs (all represented by Emord & Associates, P.C. with Attorney Jonathan Emord serving as lead counsel) will bring a lawsuit against FDA claiming the agencyâ€™s ban of four such health claims violates the First Amendment. The statements include the use of selenium to reduce the risk of lung/respiratory tract cancers, to reduce the risk of prostate cancer, to reduce the risk of other cancers, and to produce anticarcinogenic effects in the body.
The group also feels FDAâ€™s insistence on pairing a fifth claim (site-specific cancer risk reduction)Â â€œwith an inaccurate and negatively value laden disclaimerâ€ is unjust. The hope is that the U.S. District Court for the District of Columbia will find FDAâ€™s censorship unconstitutional. Read the full story.